Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06959992 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Developing Resilience in Transgender and Nonbinary Individuals - Exploring the Impact of Social Challenges in the Metaverse

Study acronym: RESILIDENT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 45 to 123v3 Show 4 more changesShow less
    • Primary and study completion dates: Feb 2026 to Dec 2026
    • Start date changed from estimate of Sep 2025 to Sep 1, 2025
    • Eligibility criteria expanded, about 7 words
    • Study description expanded, about 15 words
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date: May 2025 to Sep 2025
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to test the effectiveness of conducting a support group in the Metaverse designed to develop and/or improve resilience in gender diverse people. By exploring the impact of different social challenges in a virtual environment, the main question it aims to answer is whether this approach on conducting support group sessions with gender diverse people will strengthen their resilience and associated abilities (self-compassion) compared to a control group and a waitlist.
Trial Details
NCT Number NCT06959992
Lead Sponsor University of Bucharest
Conditions
(from sponsor)		 Resilience,Psychological, Well-Being, Psychological, Self-Compassion
Related terms Psychological Well-Being
Enrollment 123 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov